The genetic abnormality that drives the bone cancer Ewing sarcoma operates through two distinct processes, both activating genes that stimulate tumour growth and suppressing those that should keep cancer from developing. These findings by researchers from Massachusetts General Hospital (MGH) may lead to new therapies targeting these aberrant mechanisms.  The opensource study is published in the journal Cancer Cell. The second most common bone cancer … Continue reading Epigenetic methylation both stimulates and removes the brakes on Ewing sarcoma tumour growth.